Pierre Durozard
Assistance Publique Hôpitaux de Marseille(FR)Hôpital de la Timone(FR)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology
Most-Cited Works
- → Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases(2019)157 cited
- → Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis(2023)43 cited
- → Efficacy of rituximab in refractory RRMS(2018)36 cited
- → Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis(2024)17 cited
- → How Clot Composition Influences Fibrinolysis in the Acute Phase of Stroke: A Proteomic Study of Cerebral Thrombi(2024)16 cited
- → Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception(2023)15 cited
- → Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy(2021)10 cited
- → Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis(2025)8 cited
- → Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis(2025)8 cited
- → Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study(2024)8 cited